Successful treatment of chronic persistant vesicular hand dermatitis with tropical pimecrolimus

Saudi Medical Journal

Volumn 26, Issue 12, 2005, Pages 1989-1991

  Bukhari, Iqbal A ^a  

^a IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

EMOLLIENT AGENT; PIMECROLIMUS; STEROID;

ADULT; ARTICLE; CASE REPORT; CHRONIC DISEASE; CLINICAL PROTOCOL; DERMATITIS; DRUG EFFICACY; DRUG USE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HAND DISEASE; HUMAN; PATCH TEST; PHYSICAL EXAMINATION; RELAPSE; SELF MEDICATION; TREATMENT OUTCOME; VESICULAR RASH;

ADMINISTRATION, TOPICAL; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HAND DERMATOSES; HUMANS; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SKIN DISEASES, VESICULOBULLOUS; TACROLIMUS; TREATMENT OUTCOME;

EID: 31844455286     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Agrup G. Hand eczema and other hand dermatoses in South Sweden. Acta Derm Venereol (Stockh) 1969; 49 (Spppl 61): 5-91.
2. Menne T, Borgan O, Green A. Nickel allergy and hand dermatitis in a stratified sample of the Danish female population: an epidemiologic study including a statistic appendix. Acta Derm Venereol 1982; 62: 35-41.
3. Kavli G, Forde OH. Hand dermatoses in Tromso. Contact Dermatitis 1984; 10: 174-177.
4. Coenraads PJ, Nater JP, Van Der Lende R. Prevalence of eczema and other dermatoses of the hands and arms in the Netherlands. Association with age and occupation. Clin Exp Dermatol 1983; 8: 495-503.
5. Goh CL, Soh SD. Occupational dermatoses in Singapore. Contact Dermatitis 1984; 11: 288-293.
6. Warshaw E. Therapeutic options for chronic hand dermatitis. Dermatol Therapy 2004; 17: 240-250.
7. Li WF, Wang J. Contact hypersensitivity in hand dermatitis. Contact Dermatitis 2002; 47: 206-209.
8. Marks R. Adverse side effects from the use of topical corticosteroids. In: Maibach HI, Surger C, editors. Topical corticosteroids. Basel: Karger; 1992. p. 170-183.
9. Belsito DV, Fowler JF Jr, Marks JG Jr, Pariser DM, Hanifin J, Duarte IA, et al. Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis. Cutis 2004; 73: 31-38.
10. Thelmo MC, Lang W, Brooke E, Osborne BE, McCarty MA, Jorizzo JL, et al. An open-label pilot study to evaluate the safety and efficacy of topically applied tacrolimus ointment for the treatment of hand and/or foot eczema. J Dermatolog Treat 2003; 14: 136-140.
11. De Rie MA, Van Eendenburg JP, Versnick AC, Stolk LM, Bos JD, Westerhof W. A new psoralen-containing gel for topical PUVA therapy: development, and treatment results in patients with palmoplantar and plaque-type psoriasis, and hyperkeratotic eczema. Br J Dermatol 1995; 132: 964-969.
12. Grundmann-Kollmann M, Behrens S, Peter RU, Kerscher M. Treatment of severe recalcitrant dermatoses of the palms and soles with PUVA-bath versus PUVA-cream therapy. Photodermatol Photoimmunol Photomed 1999; 15: 87-89.
13. Schempp CM, Muller H, Czech W, Schopf E, Simon JC. Treatment of chronic palmoplantar eczema with local bath-PUVA therapy. J Am Acad Dermatol 1997; 36: 733-737.
14. Gritiyarangsan P, Sukhum A, Tresukosol P, Kullavanijaya P. Topical PUVA therapy for chronic hand eczema. J Dermatol 1998; 25: 299-301.
15. Schmidt T, Abeck D, Boeck K, Mempel M, Ring J. UVA1 irradiation is effective in treatment of chronic vesicular dyshidrotic hand eczema. Acta Derm Venereol (Stockh) 1998; 78: 318-319.
16. Granlund H, Erkko P, Eriksson E, Reitamo S. Comparison of cyclosporine and topical betamethasone-17, 21-dipropionate in the treatment of severe chronic hand eczema. Acta Derm Venereol 1996; 76: 371-376.
17. Petersen CS, Menne T. Cyclosporin A responsive chronic severe vesicular hand eczema. Acta Derm Venereol 1992; 72: 436-437.
18. Nousari HC, Sragovich A, Kimyai-Asadi A, Orlinsky D, Anhalt GJ. Mycophenolate mofetil in autoimmune and inflammatory skin disorders. J Am Acad Dermatol 1999; 40: 265-268.
19. Pickenacker A, Luger T, Schwarz T. Dyshidrotic eczema treated with mycophenolate mofetil. Arch Dermatol 1998; 134: 378-379.
20. Grassberger M, Baumruker T, Enz A, Hiestand P, Hultsch T, Kalthoff F, et al. A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology. Br J Dermatol 1999; 141: 264-273.
21. Kang S, Lucky AW, Pariser D, Lawrence I, Hanifin JM. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol 2001; 44: 258-264.
22. Luger T, Van Leent EJ, Graeber M, Hedgecock S, Thurston M, Kandra A, et al. SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis. Br J Dermatol 2001; 144: 788-794.
23. Thaci D, Steinmeyer K, Ebelin ME, Scott G, Kaufmann R. Occlusive treatment of chronic hand dermatitis with pimecrolimus cream 1% results in low systemic exposure is well tolerated, safe and effective. Dermatology 2003; 207: 37-42.